Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Orchestra BioMed Holdings, Inc. logo

Orchestra BioMed Holdings, Inc. (OBIO) Stock Ticker

NASDAQ: OBIO · Healthcare · Biotechnology
$5.95+0.00%
USD · as of 2026-09-28 · market cap $356.3M
Open OBIO in TickrDownload for iPhone

OBIO right now

Growing revenue 1035% a year on 99% gross margins.
Options expect by Oct 6±12.1%
Options expect by Oct 29±25.0%
Priced in for Nov 9 earnings±29.3%
IV rank (30-day)43% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full OBIO picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on OBIO
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.

OBIO stock facts

Ticker symbolOBIO
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$356.3M
CEODavid Hochman
Employees86
HeadquartersNew Hope, PA, US
IPO date2020-08-04
Websiteorchestrabiomed.com

What you can see for OBIO on Tickr

Live OBIO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the OBIO report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Orchestra BioMed Holdings, Inc.?

The ticker symbol for Orchestra BioMed Holdings, Inc. is OBIO, listed on the NASDAQ Global Market.

What is OBIO?

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for…

HomeExploreMarketLists
All pages